Primary endovascular treatment methods | | | .711a |
FAST (No.) (%) | 15 (78.9%) | 27 (84.4%) | |
Stent retriever | 4 (21.1%) | 5 (15.6%) | |
Frequency of rescue treatment | 13 (68.4%) | 6 (18.8%) | <.001 |
Switching strategy | 3 (16.7%) | 2 (6.2%) | .348a |
Intra-arterial tirofiban | 6 (31.6%) | 0 (0%) | .002a |
Stenting | 6 (31.6%) | 4 (12.5%)b | .146a |
Angioplasty | 6 (31.6%) | 4 (12.5%)b | .146a |
Reocclusion during the procedure | 11 (57.9%) | 5 (15.6%) | .002 |
Onset-to-groin puncture time (mean) (min) | 310.47 ± 136.57 | 263.13 ± 146.28 | .258 |
Door-to-groin puncture time (mean) (min) | 131.78 ± 46.94 | 137.13 ± 44.36 | .694 |
Procedure time (mean) (min) | 96.42 ± 46.03 | 61.16 ± 31.84 | .002 |
Onset-to-recanalization time (mean) (min) | 415.74 ± 128.51 | 330.66 ± 154.33 | .049 |
Successful recanalization | 17 (89.5%) | 28 (87.5%) | 1.000a |
Intracerebral hemorrhage | | | .867 |
Hemorrhagic infarction type 1 | 1 (5.3%) | 3 (9.4%) | |
Hemorrhagic infarction type 2 | 2 (10.5%) | 3 (9.4%) | |
Parenchymal hematoma type 1 | – | – | |
Parenchymal hematoma type 2 | – | – | |
Subarachnoid hemorrhage | 0 | 3 (9.4%) | .285a |
NIHSS at 7 days (median) (IQR) | 21 (9–26) | 8 (5–21.5) | .060c |
mRS 0–2 at 3 mo | 2 (10.5%) | 12 (37.5%) | .037 |
mRS 0–3 at 3 mo | 5 (26.3%) | 18 (56.2%) | .038 |
Mortality at 3 mo | 4 (21.1%) | 7 (21.9%) | 1.000a |